National Nanotechnology Initiative: Charting the Course for Reauthorization

April 24, 2008

253 SR
Nanotechnology has the potential to be the next great technological revolution. Currently, the federal investment, through the National Nanotechnology Initiative (NNI), is nearly $1.5 billion. This hearing will examine the five year period since the NNI was initially authorized in 2003 and explore issues the Committee should consider for the next reauthorization. The webcast will be audio only.

Webcast

Minority Statement

  • Ted Stevens

    Senator

Witness Panel 1

  • The Honorable Richard M. Russell

    Associate Director and Deputy Director for Technology
    Executive Office of the President
    Russell Testimony (505.50 KB)
  • Mr. Robert A. Robinson

    Managing Director, Natural Resources and Environment Team
    U.S. Government Accountability Office
    Robinson Testimony (384.61 KB)

Witness Panel 2

  • Mr. Matthew M. Nordan

    President
    Lux Research Incorporated
    Nordan Testimony (188.36 KB)
  • Mr. David Rejeski

    Director, Foresight and Governance Project and Project on Emerging Nanotechnologies
    Woodrow Wilson Center
  • Dr. P. Lee Ferguson

    Assistant Professor, Department of Chemistry and Biochemistry
    University of South Carolina
  • Dr. Anita Goel MD, PhD

    Chairman, CEO, and Scientific Director
    Nanobiosym Incorporated
    Goel Testimony (93.50 KB)
  • Dr. Jim Heath

    Director
    NSB Cancer Center
    Heath Testimony (19.75 KB)